BioSpace News Archive

Akebia Therapeutics, Inc. granted six newly-hired employees options to purchase an aggregate of 12,050 shares of Akebia’s common stock on June 29, 2018

Cigna Corporation announced that Mark McClellan, M.D., has been appointed to Cigna’s Board of Directors. Dr. McClellan’s appointment is effective December 1, 2018

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-term, continuous drug delivery technology, announced today that the independent Data Safety Monitoring Board (“DSMB”) for the company’s Phase 1/2 trial...

Healthcare technology company equipped with scalable solutions for data privacy, consent management and de-identification of personal data

Designed to meet the demanding needs of the biotech industry

TRIGR Therapeutics and ABL Bio Corporation jointly announced today that it had entered into a binding agreement for TRIGR to license the global commercial rights to ABL Bio’s pipeline of novel therapeutic antibodies to treat cancer.

On June 28, doctors at Morton Plant Hospital became the first in Florida to treat a patient in the APOLLO Transcatheter Mitral Valve Replacement (TMVR) Pivotal Trial.

American Addiction Centers (AAC) announced the winners of its 2018 Behavioral Health Academic Scholarship Program.

Universal Health Services, Inc. announced that it will report results for its second quarter ended June 30, 2018

Files Suit in Federal Court Against Former CEO Chioini, Former CFO Klema, Board Member Boyd and Former Board Member Bagley